Organogenesis Holdings Inc (FRA:2PQ)
€ 2.9 -0.12 (-3.97%) Market Cap: 383.32 Mil Enterprise Value: 396.10 Mil PE Ratio: 0 PB Ratio: 1.51 GF Score: 74/100

Organogenesis Holdings Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 09:00PM GMT
Release Date Price: €3.5 (+1.16%)
Jonathan Guskind;Executive Director;Morgan Stanley

Good afternoon, everyone. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only.

This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosures website at www.morganstanley.com/researchdisclosure. If you have any questions, please reach out to your Morgan Stanley sales representative.

Thank you all for joining the session today. My name is Jonathan Guskind, Executive Director in Morgan Stanley's Investment Banking Group. I would like to thank you all for joining us here for the continuing coverage of day 3 of the Morgan Stanley Healthcare Conference 2020. It's my pleasure to have with us here Organogenesis and the company's Chief Executive Officer, Gary Gillheeney; and Chief Operating Officer, Patrick Bilbo; as well as Interim Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot